Ventromedial Prefrontal Volume in Adolescence Predicts Hyperactive/Inattentive Symptoms in Adulthood.


Journal

Cerebral cortex (New York, N.Y. : 1991)
ISSN: 1460-2199
Titre abrégé: Cereb Cortex
Pays: United States
ID NLM: 9110718

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 06 10 2017
revised: 27 02 2018
accepted: 28 02 2018
pubmed: 19 6 2018
medline: 18 6 2020
entrez: 19 6 2018
Statut: ppublish

Résumé

Youths with attention-deficit/hyperactivity disorder symptomatology often exhibit residual inattention and/or hyperactivity in adulthood; however, this is not true for all individuals. We recently reported that dimensional, multi-informant ratings of hyperactive/inattentive symptoms are associated with ventromedial prefrontal cortex (vmPFC) structure. Herein, we investigate the degree to which vmPFC structure during adolescence predicts hyperactive/inattentive symptomatology at 5-year follow-up. Structural equation modeling was used to test the extent to which adolescent vmPFC volume predicts hyperactive/inattentive symptomatology 5 years later in early adulthood. 1104 participants (M = 14.52 years, standard deviation = 0.42; 583 females) possessed hyperactive/inattentive symptom data at 5-year follow-up, as well as quality controlled neuroimaging data and complete psychometric data at baseline. Self-reports of hyperactive/inattentive symptomatology were obtained during adolescence and at 5-year follow-up using the Strengths and Difficulties Questionnaire (SDQ). At baseline and 5-year follow-up, a hyperactive/inattentive latent variable was derived from items on the SDQ. Baseline vmPFC volume predicted adult hyperactive/inattentive symptomatology (standardized coefficient = -0.274, P < 0.001) while controlling for baseline hyperactive/inattentive symptomatology. These results are the first to reveal relations between adolescent brain structure and adult hyperactive/inattentive symptomatology, and suggest that early structural development of the vmPFC may be consequential for the subsequent expression of hyperactive/inattentive symptoms.

Identifiants

pubmed: 29912404
pii: 4975485
doi: 10.1093/cercor/bhy066
pmc: PMC6458906
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1866-1874

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103644
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : L40 MH108486
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA036114
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Références

Neuroimage. 2000 Jun;11(6 Pt 1):805-21
pubmed: 10860804
Brain. 2014 Sep;137(Pt 9):2423-8
pubmed: 24916335
Nature. 2014 Aug 14;512(7513):185-9
pubmed: 25043041
Behav Brain Res. 1998 Jul;94(1):61-71
pubmed: 9708840
Neuroimage. 2008 Feb 1;39(3):966-72
pubmed: 17996464
Am J Psychiatry. 2004 Nov;161(11):1948-56
pubmed: 15514392
Biol Psychiatry. 2007 Mar 1;61(5):720-4
pubmed: 16950228
Int J Methods Psychiatr Res. 2007;16 Suppl 1:S16-23
pubmed: 17623391
Neurosci Biobehav Rev. 2007;31(7):977-86
pubmed: 17445893
J Child Psychol Psychiatry. 1994 Oct;35(7):1247-53
pubmed: 7806608
J Neurosci. 2004 Sep 22;24(38):8223-31
pubmed: 15385605
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
Neuron. 2010 Feb 25;65(4):550-62
pubmed: 20188659
Cereb Cortex. 2007 Jun;17(6):1364-75
pubmed: 16920883
Arch Gen Psychiatry. 2006 May;63(5):540-9
pubmed: 16651511
Biol Psychiatry. 2017 Nov 1;82(9):660-668
pubmed: 28237458
Biol Psychiatry. 2005 Jun 1;57(11):1231-8
pubmed: 15949993
J Atten Disord. 2018 May;22(7):679-693
pubmed: 26515892
PLoS One. 2012;7(5):e36805
pubmed: 22629332
J Am Acad Child Adolesc Psychiatry. 1990 Jul;29(4):546-57
pubmed: 2387789
Biol Psychiatry. 2016 Dec 15;80(12):905-915
pubmed: 26115789
Psychol Assess. 2007 Jun;19(2):189-98
pubmed: 17563200
J Neurophysiol. 2010 Jul;104(1):322-35
pubmed: 20463201
Neuroimage. 2015 May 1;111:611-21
pubmed: 25725466
Neuroimage. 2003 Feb;18(2):263-72
pubmed: 12595181
Dialogues Clin Neurosci. 2012 Mar;14(1):29-37
pubmed: 22577302
Biol Psychiatry. 2006 Nov 15;60(10):1071-80
pubmed: 16876137
J Child Psychol Psychiatry. 2008 Dec;49(12):1304-12
pubmed: 19120709
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
Psychol Bull. 2017 Feb;143(2):142-186
pubmed: 28004947
Nat Neurosci. 2005 Nov;8(11):1458-63
pubmed: 16251988
Biol Psychiatry. 2018 Apr 15;83(8):638-647
pubmed: 29275839
Am J Psychiatry. 2011 Feb;168(2):143-51
pubmed: 21159727
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Neurosci Biobehav Rev. 2011 Apr;35(5):1219-36
pubmed: 21185861
J Comp Neurol. 2003 Jun 2;460(3):425-49
pubmed: 12692859
Soc Cogn Affect Neurosci. 2016 Nov;11(11):1783-1791
pubmed: 27445210
J Neurosci. 2013 Sep 4;33(36):14489-500
pubmed: 24005300
Mol Psychiatry. 2010 Dec;15(12):1128-39
pubmed: 21102431
J Youth Adolesc. 1988 Apr;17(2):117-33
pubmed: 24277579
J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):18-27.e2
pubmed: 22176936
J Neurosci. 2016 May 4;36(18):5047-54
pubmed: 27147657
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
JAMA Neurol. 2015 Nov;72(11):1252-60
pubmed: 26408865
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494

Auteurs

Matthew D Albaugh (MD)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Masha Ivanova (M)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Bader Chaarani (B)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Catherine Orr (C)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Nicholas Allgaier (N)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Robert R Althoff (RR)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Nicholas D' Alberto (N)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Kelsey Hudson (K)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Scott Mackey (S)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Philip A Spechler (PA)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Rüdiger Brühl (R)

Physikalisch-Technische Bundesanstalt [PTB], Abbestr. 2-12, Berlin-Charlottenburg, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Dublin 2, Ireland.

Uli Bromberg (U)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Christian Büchel (C)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Anna Cattrell (A)

Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Patricia J Conrod (PJ)

Department of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, QC, Canada.
Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Sylvane Desrivières (S)

Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Herta Flor (H)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Vincent Frouin (V)

Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris, France.

Jürgen Gallinat (J)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Robert Goodman (R)

King's College London Institute of Psychiatry, Psychology & Neuroscience, London, UK.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.

Yvonne Grimmer (Y)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Viola Kappel (V)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud, University Paris Descartes-Sorbonne Paris Cité.
Maison de Solenn, Paris, France.

Marie-Laure Paillère Martinot (MP)

INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, France.
University Paris Descartes, Paris, France AP-HP, Department of Adolescent Psychopathology and Medicine, Maison De Solenn, Cochin Hospital, Paris, France.

Frauke Nees (F)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (D)

Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris, France.

Jani Penttilä (J)

University of Tampere, Medical School, Tampere, Finland.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Tomáš Paus (T)

Rotman Research Institute, Baycrest and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Maren Struve (M)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Robert Whelan (R)

Department of Psychology, University College Dublin, Dublin 4, Ireland.

Gunter Schumann (G)

Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Hugh Garavan (H)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Alexandra S Potter (AS)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH